Eli Lilly's weight-loss drug retatrutide passes obesity trial
Eli Lilly on Thursday said its next-generation drug passed a crucial late-stage trial in obese patients, achieving significant weight loss…
Novo Nordisk A/S
White House Adds Generic Drugs to TrumpRx Direct-to-Consumer Site
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House in Washington,…
Novo Nordisk releases new Wegovy data on high doses
A Wegovy injection pen is shown in Waterbury, Vermont, on April 28, 2025. Shelby Knowles | Bloomberg | fake images…
Novo Nordisk CEO Mike Doustdar says Ozempic maker looking for deals
Nordisk is looking for deals more than ever, the Danish drugmaker's CEO said Wednesday in an interview with CNBC. “If…
Eli Lilly (LLY) earnings in the first quarter of 2026
Eli Lilly on Thursday reported first-quarter earnings and revenue that beat estimates and raised its full-year sales outlook by $2…
Eli Lilly Stock Rising Rapidly, Proving Stock Plunge Was a Mistake
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…
The growing LPG-1 market
When Branneisha Cooper began receiving the GLP-1 injection in Mounjaro in late 2022, she heard online that she could experience…
UnitedHealth Group (UNH) earnings in the first quarter of 2026
A UnitedHealthcare sign is displayed on its office building in Minnetonka, Minnesota, U.S., on Dec. 11, 2025. Tim Evans |…
Amazon launches GLP-1 weight loss program
Amazon GLP-1 Treatment Source: Amazon Inc. Amazon is delving into the burgeoning weight loss market, unveiling a new program Tuesday…
Novo Nordisk partners with OpenAI as hopes rise for AI drug discovery
Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday.…